| Entry |
|
|---|
| Name |
Molidustat sodium (JAN);
Musredo (TN) |
|---|
| Formula |
C13H13N8O2. Na
|
|---|
| Exact mass |
336.1059
|
|---|
| Mol weight |
336.2845
|
|---|
| Structure |
|
|---|
| Remark |
| Therapeutic category: | 3999 |
|
|---|
| Efficacy |
Anti-anemic, Hypoxia inducible factor-prolyl hydroxylase (HIF-PH) inhibitor |
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Brite |
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
39 Other agents affecting metabolism
399 Miscellaneous
3999 Others
D11273 Molidustat sodium (JAN)
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
HIF hydroxylase
EGLN (HPH)
D11273 Molidustat sodium (JAN)
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D11273
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D11273
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 24
1 C8y C 16.0300 -20.9300
2 N5x N 16.0300 -22.3300
3 C8x C 17.2424 -23.0300
4 N5x N 18.4549 -22.3300
5 C8y C 18.4549 -20.9300
6 C8x C 17.2424 -20.2300
7 N1y N 19.6860 -20.2190
8 C1x C 20.8912 -20.9147
9 C1x C 22.1035 -20.2146
10 O2x O 22.1035 -18.8146
11 C1x C 20.8983 -18.1189
12 C1x C 19.6859 -18.8190
13 N4y N 14.8176 -20.2300
14 C8y C 14.8304 -18.8300
15 C8y C 13.5053 -18.3861
16 C8x C 12.6736 -19.5092
17 N5x N 13.4847 -20.6472
18 O1a O 15.9768 -18.0129 #-
19 N4y N 13.0920 -17.0739
20 C8x C 13.9215 -15.9537
21 C8x C 13.1124 -14.8186
22 N5x N 11.7830 -15.2373
23 N5x N 11.7703 -16.6311
24 Z Na 15.7500 -15.8200 #+
BOND 26
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 5 7 1
8 7 8 1
9 8 9 1
10 9 10 1
11 10 11 1
12 11 12 1
13 7 12 1
14 1 13 1
15 13 14 1
16 14 15 2
17 15 16 1
18 16 17 2
19 13 17 1
20 14 18 1
21 15 19 1
22 19 20 1
23 21 22 1
24 22 23 2
25 19 23 1
26 20 21 2
|
|---|
